Company / Current Assets
Terns Pharmaceuticals, Inc. Current Assets History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$362.1M
FY2024
5-year range
$90.9M / $362.1M
FY2020-FY2024
Trend
+35.4%
vs FY2023
Sector context
#140 of 214
Health Care
What the data says
At $362M, Terns Pharmaceuticals, Inc.'s current assets ranks #140 of 214 in the Health Care sector. Improved from $285M to $362M over the past 2 years.
Based on SEC 10-K filings.
$362M in FY2024 with a 3-year CAGR of +29.4%.
Improved from $285M to $362M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +29.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#140 of 214 in Health CareTop 65% of 214This company $362.1M Sector average $2.5B
▼
-85.7% below sector average
Key checks
Key Insights
- 3-year CAGR of +29.4%, indicating consistent growth.
- In FY2024, current assets increased 35.4% year-over-year.
- Ranks #140 out of 214 companies in the Health Care sector.
- Lowest current assets in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 7.86 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $362.1M | +35.4% |
| FY2023 | $267.4M | -6.2% |
| FY2022 | $285.2M | +70.8% |
| FY2021 | $166.9M | +83.7% |
| FY2020 | $90.9M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026